Abbott Projects Q4 2024 Adjusted EPS Of $1.31-$1.37 Versus Consensus Of $1.2
Portfolio Pulse from Benzinga Newsdesk
Abbott Laboratories has projected its Q4 2024 adjusted earnings per share (EPS) to be between $1.31 and $1.37, surpassing the consensus estimate of $1.20.
October 16, 2024 | 11:35 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Abbott Laboratories has provided a positive earnings outlook for Q4 2024, projecting adjusted EPS between $1.31 and $1.37, which is above the consensus estimate of $1.20.
Abbott's projected EPS for Q4 2024 is higher than the consensus estimate, indicating strong expected financial performance. This positive outlook is likely to boost investor confidence and drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100